Pamela Stephenson
Corporate Officer/Principal bij DISC MEDICINE, INC.
Vermogen: 1 M $ op 31-05-2024
Actieve functies van Pamela Stephenson
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| DISC MEDICINE, INC. | Corporate Officer/Principal | 26-02-2024 | - |
Loopbaan van Pamela Stephenson
Eerdere bekende functies van Pamela Stephenson
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ZYNERBA PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 19-02-2019 | 10-10-2023 |
| Independent Dir/Board Member | 19-02-2019 | 10-10-2023 | |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01-07-2008 | 01-03-2019 |
| ALBIREO PHARMA, INC. | Corporate Officer/Principal | 25-03-2019 | - |
Opleiding van Pamela Stephenson
| Brown University | Undergraduate Degree |
| Boston University School of Public Health | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
Operationeel
| Corporate Officer/Principal | 3 |
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| ZYNERBA PHARMACEUTICALS, INC. | Health Technology |
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| DISC MEDICINE, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
- Beurs
- Insiders
- Pamela Stephenson
- Ervaring
